Merck & Co., Inc. (NYSE:MRK) is one of the best medical research stocks to buy according to hedge funds. Merck & Co., Inc.
Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved PD-L1 IHC ...
Many women believe that an infection will always cause pain, discharge, fever, or discomfort. Unfortunately, this is not always true. Some reproductive tract in ...
US FDA approves Agilent’s PD-L1 IHC 22C3 pharmDx, a companion diagnostic indicated to identify patients with epithelial ovarian, fallopian tube, or primary peritoneal carcinoma Santa Clara, California ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) approved KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ ...
A companion diagnostic test was simultaneously approved to identify eligible patients whose tumors express PD-L1 with a combined positive score of 1 or higher.
A prevention strategy developed by Canadian researchers can reduce the risk of the most common and deadly form of ovarian ...
Untreated STIs often go unnoticed but can seriously impact fertility and pregnancy. Know how silent infections in India raise risks of miscarriage and complications.
FDA approved a PD-L1 companion test to identify patients with ovarian, fallopian tube or primary peritoneal cancer who may receive first-line Keytruda. The U.S. Food and Drug Administration (FDA) has ...
We are mourning the loss of Deborah B. Lyon (64), who died surrounded by family on January 29, 2026 in Rockport, Maine. Over ...
A Nanaimo gynecologist is advocating for Island general surgery departments to roll out a procedure after a new report shows ...
HealthDay News — Opportunistic bilateral salpingectomy (OBS) is associated with a risk reduction in serous ovarian carcinoma, according to a research letter published online Feb. 2 in JAMA Network ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results